INTERfering and Co-Evolving Prevention and Therapy
ArchivedDARPA - Biological Technologies Office
Description
Under the INTERCEPT BAA-16-35, DARPA is soliciting innovative proposals for research to explore and develop therapeutic interfering particles as a novel approach to address infections from fast evolving viral pathogens.
Who can apply
- Unrestricted
Contact
James Gimlett, Ph.D. Program Manager <br/>Biological Technologies Office (BTO)
DARPA-BAA-16-35@darpa.mil
Key dates & funding
- PostedApr 28, 2016
- ClosesJul 7, 2016
- CFDA12.910
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro